查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1607963

心臟病诊断市场：通过测试、最终用户 - 2025-2030 年全球预测

Heart Attack Diagnostics Market by Test (Blood Tests, Echocardiogram, Electrocardiogram), End User (Ambulatory Surgical Centers, Diagnostics Centers, Hospital & Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年心臟病诊断市值为139.7亿美元，预计到2024年将达到149.6亿美元，复合年增长率为7.68%，预计到2030年将达到234.7亿美元。

心臟病诊断市场包括各种旨在快速准确识别心肌梗塞的工具和技术。该领域包括心电图等诊断测试、肌钙蛋白等心臟生物标记的血液测试以及先进的诊断成像技术。这项需求源于对早期准确检测的迫切需要，以改善患者预后并降低死亡率。这些诊断的应用范围很广，包括急诊室就诊、高风险个体的例行检查以及持续监测技术。从最终用途来看，医院、诊所和研究机构是主要用户，但个人健康监测设备在家庭医疗保健环境中的应用也呈现成长趋势。

主要市场统计
基准年[2023] 139.7亿美元
预测年份 [2024] 149.6亿美元
预测年份 [2030] 234.7亿美元
复合年增长率（%） 7.68%

关键的成长要素包括由于生活方式的改变、人口老化以及可提供更快、更准确结果的诊断技术的进步，心血管疾病的盛行率不断增加。新的商机在于人工智慧和机器学习的整合，以增强诊断能力和开发非侵入性就地检验解决方案。公司可以利用这些机会，透过投资研发以及与科技公司建立策略伙伴关係来更快地创新。

然而，市场成长面临挑战，例如严格的监管要求需要时间来产品核可，以及先进诊断设备的高成本，这可能成为新兴市场的障碍。诊断测试的潜在不准确性以及对资源匮乏地区医疗保健基础设施的依赖也产生了限制。

您可以追求创新，例如开发可在偏远地区和都市区使用的可携式、经济高效的设备，以及改进用于预测诊断的人工智慧演算法以帮助预防性护理。市场竞争激烈，龙头企业纷纷透过併购来丰富产品线，充满活力的成长环境已成熟。总体而言，持续投资于技术进步和遵守监管标准对于充分发挥心臟病诊断市场的潜力至关重要。

市场动态：快速发展的心臟病诊断市场的关键市场洞察

供需的动态交互作用正在改变心臟病诊断市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 年轻一代和成年人中心血管疾病的盛行率不断增加
    • 消费者预防保健意识不断增强
    • 增加久坐的生活方式
  • 市场限制因素
    • 心臟病诊断设备高成本
  • 市场机会
    • 医学影像处理技术创新
    • 人工智慧和机器学习在心臟病诊断药物中的部署
  • 市场挑战
    • 缺乏技术精湛、经验丰富的专业人员

波特的五力：驾驭心臟病诊断市场的策略工具

波特的五力框架是了解心臟病诊断市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对心臟病诊断市场的影响

外部宏观环境因素在塑造心臟病诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解心臟病诊断药物市场的竞争状况

对心臟病诊断市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心臟病诊断市场供应商的绩效评估

FPNV定位矩阵是评估心臟病诊断市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划心臟病诊断市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，心臟病诊断市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 年轻人和成年人中心血管疾病的盛行率不断增加
      • 提高消费者预防保健意识
      • 更采用久坐的生活方式
    • 抑制因素
      • 心臟病诊断设备高成本
    • 机会
      • 医学影像技术创新
      • 在心臟病诊断中引入人工智慧和机器学习
    • 任务
      • 缺乏技术精湛、经验丰富的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 心臟病诊断药物市场测试

  • 验血
  • 心臟超音波图
  • 心电图

第七章心臟病诊断市场：依最终用户分类

  • 门诊手术中心
  • 诊断中心
  • 医院/诊所

第八章 北美和南美心臟病诊断药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区心臟病诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲心臟病诊断药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories Inc.
  • ACS Diagnostics Inc.
  • Asahi Kasei Corporation
  • Bio-Rad Laboratories Inc.
  • Bionet Co., Ltd.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Danaher Corporation
  • F. Hoffmann La-Roche Ltd.
  • FUJIFILM Holdings Corp.
  • GE Healthcare Inc.
  • Hill Rom Holdings Inc. by Baxter International Inc.
  • Koninklijke Philips NV
  • Nihon Kohden Corp.
  • Siemens Healthineers AG
Product Code: MRR-3E376243AABD

The Heart Attack Diagnostics Market was valued at USD 13.97 billion in 2023, expected to reach USD 14.96 billion in 2024, and is projected to grow at a CAGR of 7.68%, to USD 23.47 billion by 2030.

The heart attack diagnostics market encompasses a range of tools and technologies designed to rapidly and accurately identify myocardial infarctions. The scope of this sector includes diagnostic tests such as electrocardiograms, blood tests for cardiac biomarkers like troponins, and advanced imaging techniques. Its necessity stems from the urgent need for early and precise detection to improve patient outcomes and reduce mortality rates. Applications of these diagnostics span emergency room settings, routine check-ups for at-risk individuals, and continuous monitoring technologies. In terms of end-use scope, hospitals, clinics, and research institutes are the primary users, though there's a rising trend towards personal health monitoring devices in home healthcare settings.

KEY MARKET STATISTICS
Base Year [2023] USD 13.97 billion
Estimated Year [2024] USD 14.96 billion
Forecast Year [2030] USD 23.47 billion
CAGR (%) 7.68%

Key growth factors include the increasing prevalence of cardiovascular diseases due to lifestyle changes, aging populations, and advancements in diagnostic technologies that offer faster results with higher accuracy. Emerging opportunities lie in the integration of artificial intelligence and machine learning to enhance diagnostic capabilities and the development of non-invasive and point-of-care testing solutions. Companies can capitalize on these opportunities by investing in R&D and forming strategic partnerships with technology firms to innovate faster.

However, market growth faces challenges such as the high cost of advanced diagnostic equipment, which can be a barrier in emerging markets, alongside stringent regulatory requirements that elongate product approval times. Limitations also arise from potential inaccuracies in diagnostic tests and dependence on healthcare infrastructure in low-resource settings.

Innovation can be pursued in creating portable, cost-effective devices suitable for both remote and urban areas, and improving AI algorithms for predictive diagnostics, which can aid in preventive healthcare. The market is highly competitive, with major players focusing on mergers and acquisitions to enhance their product offerings, indicating a dynamic environment ripe for growth. Overall, continued investment in technological advancement and meeting regulatory standards are essential to harness the full potential of the heart attack diagnostics market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Heart Attack Diagnostics Market

The Heart Attack Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of cardiovascular disease among younger and adult generation
    • Rising consumer awareness for preventive health
    • Higher adoption of sedentary lifestyles
  • Market Restraints
    • High cost of heart attack diagnostic equipments
  • Market Opportunities
    • Innovations in medical imaging technology
    • Deployment of AI and ML in heart attack diagnostics
  • Market Challenges
    • Lack of skilled and experienced professionals

Porter's Five Forces: A Strategic Tool for Navigating the Heart Attack Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Heart Attack Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Heart Attack Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Heart Attack Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Heart Attack Diagnostics Market

A detailed market share analysis in the Heart Attack Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Heart Attack Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Heart Attack Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Heart Attack Diagnostics Market

A strategic analysis of the Heart Attack Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Heart Attack Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., ACS Diagnostics Inc., Asahi Kasei Corporation, Bio-Rad Laboratories Inc., Bionet Co., Ltd., Boston Scientific Corporation, Canon Medical Systems Corporation, Danaher Corporation, F. Hoffmann La-Roche Ltd., FUJIFILM Holdings Corp., GE Healthcare Inc., Hill Rom Holdings Inc. by Baxter International Inc., Koninklijke Philips N.V., Nihon Kohden Corp., and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the Heart Attack Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test, market is studied across Blood Tests, Echocardiogram, and Electrocardiogram.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostics Centers, and Hospital & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of cardiovascular disease among younger and adult generation
      • 5.1.1.2. Rising consumer awareness for preventive health
      • 5.1.1.3. Higher adoption of sedentary lifestyles
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of heart attack diagnostic equipments
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations in medical imaging technology
      • 5.1.3.2. Deployment of AI and ML in heart attack diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled and experienced professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Heart Attack Diagnostics Market, by Test

  • 6.1. Introduction
  • 6.2. Blood Tests
  • 6.3. Echocardiogram
  • 6.4. Electrocardiogram

7. Heart Attack Diagnostics Market, by End User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Diagnostics Centers
  • 7.4. Hospital & Clinics

8. Americas Heart Attack Diagnostics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Heart Attack Diagnostics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Heart Attack Diagnostics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories Inc.
  • 2. ACS Diagnostics Inc.
  • 3. Asahi Kasei Corporation
  • 4. Bio-Rad Laboratories Inc.
  • 5. Bionet Co., Ltd.
  • 6. Boston Scientific Corporation
  • 7. Canon Medical Systems Corporation
  • 8. Danaher Corporation
  • 9. F. Hoffmann La-Roche Ltd.
  • 10. FUJIFILM Holdings Corp.
  • 11. GE Healthcare Inc.
  • 12. Hill Rom Holdings Inc. by Baxter International Inc.
  • 13. Koninklijke Philips N.V.
  • 14. Nihon Kohden Corp.
  • 15. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. HEART ATTACK DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. HEART ATTACK DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HEART ATTACK DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HEART ATTACK DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEART ATTACK DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEART ATTACK DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. HEART ATTACK DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. HEART ATTACK DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023